Publications by authors named "Kayoko Kikuchi"

Claim this Profile
P
Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics (Clostridium butyricum, Enterococcus faecium, and Bacillus subtilis; PPP Trial): Protocol for a Prospective, Single-Arm, Nonblinded, Multicenter Trial.
Satoshi Yoneda, Tohru Kobayashi, Kayoko Kikuchi, Shintaro Iwamoto, Tsuyoshi Teramoto

JMIR Res Protoc· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, 2-dose single-group controlled trial of tacrolimus for the severe infertility patients.
Michi Hisano, Koji Nakagawa, Masanori Ono, Osamu Yoshino, Takakazu Saito, Kayoko Kikuchi

Medicine (Baltimore)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Fumihiko Namba, Masakazu Honda, Shun Sakatani, Yukiko Motojima, Kayoko Kikuchi

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot).
Kenichi Sakamoto, Kayoko Kikuchi, Mayumi Sako, Miho Kato, Tetsuya Takimoto

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries.
Hiroyuki Taruno, Mari S Oba, Osamu Takizawa, Kayoko Kikuchi, Kazuaki Matsui

BMJ Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.
Masato Fujioka, Takumi Akiyama, Makoto Hosoya, Kayoko Kikuchi, Yuto Fujiki

Medicine (Baltimore)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.
Yoshitaka Miyakawa, Shinya Katsutani, Takahiro Yano, Shosaku Nomura, Kaichi Nishiwaki, Kayoko Kikuchi

Int J Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
Kayoko Kikuchi, Yoshitaka Miyakawa, Shunya Ikeda, Yuji Sato, Toru Takebayashi

BMC Health Serv Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis